Folgen
Vipendra Kumar
Vipendra Kumar
Postdoctoral Research Associate at University of Illinois at Urbana-Champaign
Bestätigte E-Mail-Adresse bei illinois.edu
Titel
Zitiert von
Zitiert von
Jahr
Efficient inhibition of protein aggregation, disintegration of aggregates, and lowering of cytotoxicity by green tea polyphenol-based self-assembled polymer nanoparticles
K Debnath, S Shekhar, V Kumar, NR Jana, NR Jana
ACS applied materials & interfaces 8 (31), 20309-20318, 2016
1182016
Glycogen synthase protects neurons from cytotoxicity of mutant huntingtin by enhancing the autophagy flux
A Rai, PK Singh, V Singh, V Kumar, R Mishra, AK Thakur, A Mahadevan, ...
Cell death & disease 9 (2), 201, 2018
362018
Hyperexcitability and homeostasis in fragile X syndrome
X Liu, V Kumar, NP Tsai, BD Auerbach
Frontiers in Molecular Neuroscience 14, 805929, 2022
352022
Azadiradione restores protein quality control and ameliorates the disease pathogenesis in a mouse model of Huntington’s disease
BK Singh, N Vatsa, VK Nelson, V Kumar, SS Kumar, SC Mandal, M Pal, ...
Molecular neurobiology 55, 6337-6346, 2018
342018
Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1δE9 mouse model of Alzheimer’s disease
BK Singh, N Vatsa, V Kumar, S Shekhar, A Sharma, NR Jana
Human Molecular Genetics 26 (20), 4042-4054, 2017
282017
Rescue of altered HDAC activity recovers behavioural abnormalities in a mouse model of Angelman syndrome
I Jamal, V Kumar, N Vatsa, S Shekhar, BK Singh, A Sharma, NR Jana
Neurobiology of Disease 105, 99-108, 2017
282017
Deficiency of Ube3a in Huntington's disease mice brain increases aggregate load and accelerates disease pathology
M Maheshwari, S Shekhar, BK Singh, I Jamal, N Vatsa, V Kumar, ...
Human molecular genetics 23 (23), 6235-6245, 2014
272014
Withaferin A Induces Heat Shock Response and Ameliorates Disease Progression in a Mouse Model of Huntington's Disease
NRJ Tripti Joshi, Vipendra Kumar, Elena V Kaznacheyeva
Molecular Neurobiology, 2021
252021
Down-regulation of miRNA-708 promotes aberrant calcium signaling by targeting neuronatin in a mouse model of angelman syndrome
N Vatsa, V Kumar, BK Singh, SS Kumar, A Sharma, NR Jana
Frontiers in Molecular Neuroscience 12, 35, 2019
232019
Environmental enrichment improves behavioral abnormalities in a mouse model of Angelman syndrome
I Jamal, V Kumar, N Vatsa, BK Singh, S Shekhar, A Sharma, NR Jana
Molecular neurobiology 54, 5319-5326, 2017
152017
Simvastatin restores HDAC1/2 activity and improves behavioral deficits in Angelman syndrome model mouse
V Kumar, T Joshi, N Vatsa, BK Singh, NR Jana
Frontiers in Molecular Neuroscience 12, 289, 2019
142019
Topoisomerase 1 inhibitor topotecan delays the disease progression in a mouse model of Huntington’s disease
S Shekhar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana
Human molecular genetics 26 (2), 420-429, 2017
112017
mGluR7 allosteric modulator AMN082 corrects protein synthesis and pathological phenotypes in FXS
V Kumar, KY Lee, A Acharya, MS Babik, CA Christian-Hinman, ...
EMBO Molecular Medicine 16 (3), 506-522, 2024
22024
Role of simvastatin in restoration of behavioral and synaptic deficits in Angelman syndrome mouse model
V Kumar, T Joshi, NR Jana
IBRO Reports 6, S248, 2019
2019
Topotecan, a Topoisomerase-1 Inhibitor, Retards the Disease Pathogenesis in a Mouse Model of Huntington's Disease
SS Kumar, N Vatsa, V Kumar, BK Singh, I Jamal, A Sharma, NR Jana
NEUROTHERAPEUTICS 15 (1), 252-252, 2018
2018
Ube3a deficiency inhibits amyloid plaque formation in APPswe/PS1dE9 mouse model of Alzheimer’s disease
BK Singh, N Vatsa, V Kumar, S Shekhar, A Sharma, NR Jana
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–16